The field spans a broad technology base. DNA synthesis and assembly, genome engineering, metabolic engineering, protein and enzyme engineering, synthetic genomics and computational design form the core toolset, supported by automated biofoundries, biosensors, robotics and expanding capability in xenobiology and cell-free systems. These tools are deployed across an unusually wide range of end markets - pharmaceuticals and healthcare, bio-based chemicals, bioplastics and biopolymers, biofuels, agriculture, food and nutraceutical ingredients, textiles, packaging, cosmetics, surfactants, construction materials, biocatalysis and bioremediation.
Three structural shifts define the current period. The first is convergence: synthetic biology, industrial enzymes and white biotechnology were historically analysed as separate sectors; they now share the same toolsets, the same customers and increasingly the same balance sheets, making separate segmentation artificial and treating them as one industrial biomanufacturing market more accurate. The second is the elevation of policy from background condition to primary determinant, with regulatory frameworks and industrial strategy in the European Union, United States and Asia now materially shaping where production capacity is built and which products reach market first.
The third, and the most important commercially, is that scale-up remains the binding constraint. Laboratory and bench results reproduce reliably. The transition to commercial fermentation volumes exposes oxygen transfer limits, heat removal constraints, contamination risk, feedstock variability and downstream recovery losses that were invisible at small scale and that routinely destroy process economics. This gap explains the recurring pattern of well-funded platform companies failing between late-stage financing and commercial launch. The consequence is a bifurcating market: companies with production assets, contract manufacturing relationships or access to shared pilot infrastructure are converting technical capability into revenue, while those licensing technology alone remain exposed to the biotechnology funding cycle. Consolidation is expected to continue.
This report provides a comprehensive analysis of the global synthetic biology and biomanufacturing market across the 2027-2037 period, with historical context from 2019. It assesses the technical, commercial and regulatory factors shaping the sector, and segments the market by technology platform, product type, application sector and geography. Coverage extends across the applications in which synthetic biology is being commercialised: biofuels, bio-based chemicals, bioplastics and biopolymers, bioremediation, biocatalysis, food and nutraceutical ingredients, sustainable agriculture, textiles, packaging, healthcare and pharmaceuticals, cosmetics, surfactants and detergents, and construction materials.
The report includes a detailed technology roadmap to 2037, SWOT analysis, assessment of industry challenges and constraints, analysis of the scale-up and pilot infrastructure bottleneck, the regulatory and policy landscape across the European Union, United States and Asia, the industrial biotechnology value chain, the convergence of synthetic biology with industrial enzymes and white biotechnology, and a review of investment activity across the sector. It contains 137 tables, 68 figures and profiles of 327 companies spanning the synthetic biology value chain, from DNA synthesis and biofoundry platforms through fermentation producers, materials companies and end-market brands.
Contents include:
- Executive summary - overview of the global market; difference between synthetic biology and genetic engineering; market size and growth by technology, product type, market and region; major trends and drivers; investments; technology roadmap; convergence of synthetic biology, industrial enzymes and white biotechnology; regulatory and policy landscape; colours of biotechnology; industrial biotechnology value chain
- Introduction - what is synthetic biology; comparison with conventional processes; applications; advantages; sustainability; synthetic biology for the circular economy
- Technology analysis - biomanufacturing processes (batch, continuous, fermentation, cell-free, biofilm, microfluidic, photobioreactors, membrane bioreactors, plant and mammalian cell culture, bioprinting); cell factories; metabolic engineering; gene and DNA synthesis; genome engineering (CRISPR, TALENs, ZFNs); protein/enzyme engineering; synthetic genomics; strain construction; smart bioprocessing; chassis organisms; biomimetics; robotics and automation; bioinformatics; xenobiology; biosensors; feedstocks; marine biotechnology
- Market analysis - trends and drivers; industry challenges; bioeconomy; SWOT; markets across biofuels, bio-based chemicals, bioplastics and biopolymers, bioremediation, biocatalysis, food and nutraceutical ingredients, sustainable agriculture, textiles, packaging, healthcare and pharmaceuticals, cosmetics, surfactants and detergents, and construction materials
- Global market revenues 2019-2037 by technology, product type, market and region; scale-up and pilot infrastructure; natural molecule drug discovery; future market outlook
- Company profiles - 327 profiles spanning the synthetic biology value chain
- Appendix - research methodology and glossary; references
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aanika Biosciences
- Aemetis
- AEP Polymers
- Afyren
- AgBiome
- AgriSea NZ Seaweed
- Agrivida
- Ainnocence
- AIO
- AI Proteins
- Algal Bio
- Algenol
- AlgiKnit
- Algiecel
- Alpha Biofuels
- Allonnia
- Allozymes
- Alt.Leather
- Alto Neuroscience
- Amano Enzyme
- AmphiStar
- Amply Discovery
- AMSilk
- Amyris
- Andes Ag
- Ansa Biotechnologies
- Antheia
- Apeel Sciences
- Aralez Bio
- Arctic Biomaterials
- Ardra Bio
- Arkeon
- Arsenale Bioyards
- Arzeda
- Asimov
- Atantares
- Autolus
- AVA Biochem
- Avantium
- Azolla
- Axcelon Biopolymers
- Basecamp Research
- BBCA Biochemical & GALACTIC Lactic Acid
- Benefuel
- BioBetter
- Bioextrax
- Bio Fab NZ
- Biokemik
- BIOLO
- Biomason
- Biomemory
- Bioplastech
- BioSmart Nano
- Biotic Circular Technologies
- Biosyntia
- Biotecam
- Bioweg
- bit.bio
- Bloom Biorenewables
- BluCon Biotech
- Blue BioFuels
- Bluepha
- Bon Vivant
- Bolt Threads
- Bosk Bioproducts
- Bowil Biotech
- Braskem
- Brightseed
- Bucha Bio
- C1 Green Chemicals
- C16 Biosciences
- CABIO Biotech
- California Cultured
- Calysta
- Cambrium
- Camena Bioscience
- Capra Biosciences
- Carbios
- Cargill
- Calyxt
- Cascade Biocatalysts
- Cass Materials
- Catalyxx
- Cathy Biotech
- Cauldron Ferm
- Cemvita Factory
- ChainCraft
- Checkerspot
- Chitose Bio Evolution
- CinderBio
- Circe
- CJ Biomaterials
- Clean Food Group
- Codagenix
- Codexis
- Colossal Biosciences
- Colipi
- Colorifix
- Conagen
- Constructive Bio
- Cysbio
- Danimer Scientific
- Debut Biotechnology
- Deep Branch Biotechnology
- Demetrix
- Dispersa
- DMC Biotechnologies
- DNA Script
- Domsjo Fabriker
- DoriNano
- DuPont
- Earli
- Ecovative Design
- Eco Fuel Technology
- Eden Brew
- EggPlant
- Eligo Bioscience
- Elo Life Systems
- Emerging Fuels Technology
- Enduro Genetics
- EnginZyme
- Eni
- EnPlusOne Biosciences
- Enzymaster
- Enzymit
- Erebagen
- Esphera SynBio
- Euglena
- Eversyn
- Evozyne
- FabricNano
- Fermentalg
- Forage Evolution
- and more......

